Prolonged regulatable expression of EPO from an HSV vector using the LAP2 promoter element
about
HSV-mediated gene transfer of C3 transferase inhibits Rho to promote axonal regeneration.Targeted drug delivery to the peripheral nervous system using gene therapy.Progress in gene therapy for neurological disorders.Herpes simplex virus-based nerve targeting gene therapy in pain management.Regulatable Transgene Expression for Prevention of Chemotherapy-Induced Peripheral Neuropathy.
P2860
Prolonged regulatable expression of EPO from an HSV vector using the LAP2 promoter element
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Prolonged regulatable expressi ...... sing the LAP2 promoter element
@en
Prolonged regulatable expressi ...... ing the LAP2 promoter element.
@nl
type
label
Prolonged regulatable expressi ...... sing the LAP2 promoter element
@en
Prolonged regulatable expressi ...... ing the LAP2 promoter element.
@nl
prefLabel
Prolonged regulatable expressi ...... sing the LAP2 promoter element
@en
Prolonged regulatable expressi ...... ing the LAP2 promoter element.
@nl
P2093
P2860
P356
P1433
P1476
Prolonged regulatable expressi ...... sing the LAP2 promoter element
@en
P2093
P2860
P2888
P304
P356
10.1038/GT.2011.188
P577
2011-11-17T00:00:00Z
P5875
P6179
1011314829